ROLE OF INTERLEUKIN‐6 IN THE PATHOGENESIS OF MULTIPLE MYELOMA
@article{Gad2000ROLEOI, title={ROLE OF INTERLEUKIN‐6 IN THE PATHOGENESIS OF MULTIPLE MYELOMA}, author={K. Gad{\'o} and G. Domj{\'a}n and H. Hegyesi and A. Falus}, journal={Cell Biology International}, year={2000}, volume={24} }
Multiple myeloma (MM) is a currently incurable disease caused by the proliferation of malignant plasma cells. Although the pathogenesis of the disease still remains unclear, recent research in the biology of MM has produced new insights into the factors that control the growth and survival of myeloma cells. Among the growth factors, interleukin‐6 (IL‐6) has an essential role. Evidence suggests that IL‐6 is not only a growth factor, but also a survival factor in MM, inhibiting apoptosis in… CONTINUE READING
Topics from this paper
101 Citations
Targeting signalling pathways for the treatment of multiple myeloma
- Biology, Medicine
- Expert opinion on therapeutic targets
- 2005
- 31
The role of IL-29 in immunity and cancer
- Biology, Medicine
- Critical Reviews in Oncology/Hematology
- 2016
- 12
Activation of sphingosine kinase mediates suppressive effect of interleukin‐6 on human multiple myeloma cell apoptosis
- Biology, Medicine
- British journal of haematology
- 2007
- 27
Extracellular S100A9 Protein in Bone Marrow Supports Multiple Myeloma Survival by Stimulating Angiogenesis and Cytokine Secretion
- Biology, Medicine
- Cancer Immunology Research
- 2017
- 12
- PDF
Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells
- Biology, Medicine
- Leukemia
- 2002
- 42
- PDF
The malignant clone and the bone-marrow environment.
- Biology, Medicine
- Best practice & research. Clinical haematology
- 2007
- 85
References
SHOWING 1-10 OF 133 REFERENCES
Interleukin‐6 in multiple myeloma and related plasma cell dyscrasias
- Medicine
- Current opinion in hematology
- 1998
- 78
Cytokine network in human multiple myeloma.
- Medicine
- Hematology/oncology clinics of North America
- 1992
- 151
Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells
- Biology, Medicine
- The Journal of experimental medicine
- 1994
- 49
- PDF
Soluble interleukin‐6 receptor as a prognostic factor in multiple myeloma
- Medicine
- British journal of haematology
- 1996
- 80
Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
- Biology, Medicine
- Journal of immunology
- 1996
- 26
Molecular analysis of the IL‐6 receptor in human multiple myeloma, an IL‐6‐related disease
- Biology, Medicine
- FEBS letters
- 1994
- 16